Oppenheimer & Co. Inc. Sells 54,739 Shares of Aflac Incorporated (NYSE:AFL)

Oppenheimer & Co. Inc. lessened its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 29.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 128,757 shares of the financial services provider's stock after selling 54,739 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Aflac were worth $14,395,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sei Investments Co. boosted its holdings in Aflac by 0.9% during the first quarter. Sei Investments Co. now owns 301,433 shares of the financial services provider's stock worth $25,881,000 after purchasing an additional 2,712 shares during the last quarter. Koshinski Asset Management Inc. acquired a new position in Aflac during the first quarter worth $832,000. State Board of Administration of Florida Retirement System boosted its holdings in Aflac by 3.3% during the first quarter. State Board of Administration of Florida Retirement System now owns 718,067 shares of the financial services provider's stock worth $61,653,000 after purchasing an additional 22,637 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Aflac by 13.9% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 708,248 shares of the financial services provider's stock worth $60,810,000 after acquiring an additional 86,578 shares in the last quarter. Finally, Zega Financial LLC raised its position in Aflac by 0.7% during the first quarter. Zega Financial LLC now owns 68,035 shares of the financial services provider's stock worth $5,841,000 after acquiring an additional 500 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company's stock.

Aflac Price Performance

Aflac stock traded down $0.21 during trading hours on Wednesday, reaching $110.44. 1,456,766 shares of the stock were exchanged, compared to its average volume of 2,229,972. The company has a market cap of $61.35 billion, a P/E ratio of 16.63, a price-to-earnings-growth ratio of 2.13 and a beta of 0.96. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.32. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50. The stock has a 50 day moving average of $110.36 and a two-hundred day moving average of $99.14.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, beating analysts' consensus estimates of $1.69 by $0.47. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The company had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. During the same period last year, the company posted $1.84 EPS. The firm's quarterly revenue was down 40.4% compared to the same quarter last year. Equities analysts expect that Aflac Incorporated will post 7.22 EPS for the current fiscal year.

Aflac Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th will be paid a $0.50 dividend. The ex-dividend date is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.81%. Aflac's payout ratio is currently 30.12%.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Evercore ISI upped their price target on shares of Aflac from $84.00 to $90.00 and gave the stock an "underperform" rating in a research report on Thursday, September 26th. Truist Financial increased their price objective on shares of Aflac from $100.00 to $105.00 and gave the company a "hold" rating in a research report on Friday, November 1st. UBS Group increased their price objective on shares of Aflac from $84.00 to $109.00 and gave the company a "neutral" rating in a research report on Wednesday, August 14th. Piper Sandler increased their price objective on shares of Aflac from $114.00 to $122.00 and gave the company an "overweight" rating in a research report on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. increased their price objective on shares of Aflac from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Thursday, October 3rd. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $97.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.